Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out
By Adam Lidgett · March 24, 2025, 8:25 PM EDT
Amgen has urged a Delaware federal court to grant it a new trial after a federal jury last year found that it owed Germany's Lindis Biotech $50.3 million in damages for...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login